Entering text into the input field will update the search result below

Allergan's Tobira takeover stokes NASH stocks

  • Once investors catch their collective breath over Allergan's (NYSE:AGN) wildly bullish takeout of Tobira Therapeutics (NASDAQ:TBRA), they may want to keep an eye on other NASH players. Some, of course, have more credibility than others.
  • Premarket movers: MediciNova (NASDAQ:MNOV+3.3%; Regulus Pharmaceuticals (NASDAQ:RGLS+3.1%; Intercept Pharmaceuticals (NASDAQ:ICPT+6.0%; Conatus Pharmaceuticals (NASDAQ:CNAT+38.3%; Galectin Therapeutics (NASDAQ:GALT+24.0%; Shire plc (NASDAQ:SHPG): +1.0%; Can-Fite BioPharma (NYSEMKT:CANF+23.1%.
  • Others: Galmed Pharmaceuticals (NASDAQ:GLMD); Vascular Biogenics (NASDAQ:VBLT); Islet Sciences (OTC:ISLT); Genfit (OTCPK:GNFTF).

Recommended For You

Related Stocks

SymbolLast Price% Chg
AGN--
Allergan plc